Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Vigil Neuroscience, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 50 | 78 | +28 |
| Shares | 25.0M | 33.4M | +8.40M (+33.6%) |
| Value | $44.5M | $265.8M | +$221.2M (+496.6%) |
New holders (46)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (18)
Institutions that held Vigil Neuroscience, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| BVF Inc | 4,013,633 | $7.14M |
| Standard Life Aberdeen plc | 1,724,520 | $3.07M |
| Sphera Funds Management Ltd. | 1,604,429 | $2.86M |
| Ensign Peak Advisors, Inc | 1,578,116 | $2.81M |
| Blair William & Co | 1,033,577 | $1.84M |
| Rock Springs Capital Management LP | 471,958 | $840.1K |
| Susquehanna International Group, LLP | 212,640 | $378.5K |
| LPL Financial LLC | 80,959 | $144.1K |
| Bridgeway Capital Management, LLC | 79,864 | $142.2K |
| Boothbay Fund Management, LLC | 73,375 | $130.6K |
| Acadian Asset Management LLC | 35,555 | $62.0K |
| Two Sigma Advisers, LP | 17,900 | $31.9K |
| Jane Street Group, LLC | 16,587 | $29.5K |
| Cubist Systematic Strategies, LLC | 15,161 | $27.0K |
| Barclays PLC | 12,688 | $22.6K |
| Dimensional Fund Advisors LP | 10,704 | $19.1K |
| Tower Research Capital LLC (TRC) | 3,044 | $5.42K |
| Coldstream Capital Management Inc | 187 | $333 |